The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prostate cancer incidence in males with Lynch syndrome.
Sigurdis Haraldsdottir
No relevant relationships to disclose
Heather Hampel
No relevant relationships to disclose
Lai Wei
No relevant relationships to disclose
Christina Sing-Ying Wu
No relevant relationships to disclose
Tanios S. Bekaii-Saab
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; Sanofi
Albert De La Chapelle
No relevant relationships to disclose
Richard M. Goldberg
Consultant or Advisory Role - Bayer (U); Jennerex Biotherapeutics (U); Lilly; Myriad Genetics (U); Sanofi (U)
Research Funding - Bayer; Sanofi